Progen Co (XKRX:296160) EPS (Basic): ₩ (TTM As of Dec. 2025)


What is Progen Co EPS (Basic)?

Progen Co XKRX:296160 +0.15% EPS (Basic) is ₩ as of Dec. 2025. The stock has 3 warning signs investors should review.

Progen Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was ₩-1,393.00. Progen Co does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025.

Progen Co's EPS (Diluted) for the six months ended in Dec. 2025 was ₩-1,393.00. Progen Co does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025.

Progen Co's EPS without NRI for the six months ended in Dec. 2025 was ₩-1,410.12. Progen Co does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Progen Co  (XKRX:296160) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Progen Co EPS (Basic) Related Terms

Progen Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Progen Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progen Co EPS (Basic) Chart

Progen Co Annual Data
Trend Dec23 Dec24 Dec25
EPS (Basic)
936.00 -516.00 -1,393.00

Progen Co Semi-Annual Data
Dec23 Dec24 Dec25
EPS (Basic) 936.00 -516.00 -1,393.00

Progen Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Progen Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-20091.616-0)/14.423
=-1,393.03

Progen Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-20091.616-0)/14.423
=-1,393.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₩ mean?
Progen Co (XKRX:296160) has a EPS (Basic) of ₩ as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Progen Co and its competitors.
Is Progen Co's EPS (Basic) too high?
Progen Co's current EPS (Basic) is ₩.
How does Progen Co's EPS (Basic) compare to VRTX and REGN?
Progen Co's EPS (Basic) of ₩ can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Progen Co and its competitors. Progen Co's current EPS (Basic) is ₩. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progen Co stock overvalued right now?
Progen Co (XKRX:296160) has a current EPS (Basic) of ₩. The current EPS (Basic) is ₩. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Progen Co (XKRX:296160), the current EPS (Basic) is ₩ as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Progen Co Business Description

Address 172 Magokjungang-ro, 7th Floor, Bio Innovation Park, Gangseo-gu, Seoul, KOR
Progen Co Ltd is an R&D focused biopharmaceutical development venture. It is engaged in developing metabolic disease treatments, immune disease treatments, and immune anti cancer drugs using its immunology based drug development know how, and is focusing on developing inventive drugs through domestic and international open innovation.